Chemomab Therapeutics (CMMB) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Chemomab Therapeutics Ltd. has released its unaudited interim condensed consolidated financial statements for the period ending June 30, 2024. The statements show a decrease in total current assets from the previous year-end, with figures moving from $20,897 thousand to $13,455 thousand. The report also details changes in liabilities, including trade payables and accrued expenses.
For further insights into CMMB stock, check out TipRanks’ Stock Analysis page.
